JAK2V617F mutation in leukaemic transformation of philadelphia-negative chronic myeloproliferative disorders [3]

British Journal of Haematology

Volumn 135, Issue 2, 2006, Pages 267-268

  Rossi, Davide ^a   Deambrogi, Clara ^a   Capello, Daniela ^a   Cerri, Michaela ^a   Lunghi, Monia ^a   Parvis, Guido ^b   Saglio, Giuseppe ^b   Gaidano, Gianluca ^a   Cilloni, Daniela ^b  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Acute myeloid leukaemia; Essential thrombocythaemia; Idiopathic myelofibrosis; JAK2; Polycythaemia vera

Indexed keywords

JANUS KINASE 2; PROTEIN P53;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE MUTATION; HUMAN; KARYOTYPE; LETTER; LEUKEMOGENESIS; MALE; MALIGNANT TRANSFORMATION; MUTATIONAL ANALYSIS; MYELOPROLIFERATIVE DISORDER; PHILADELPHIA CHROMOSOME NEGATIVE CELL; PRIORITY JOURNAL; THROMBOCYTHEMIA;

ACUTE DISEASE; ADULT; AGED; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; JANUS KINASE 2; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; PHILADELPHIA CHROMOSOME; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS;

EID: 33748752215     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06288.x     Document Type: Letter

References (6)

1. Baxter, E.J., Scott, L.M., Campbell, P.J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G.S., Bench, A.J., Boyd, E.M., Curtin, N., Scott, M.A., Erber, W.N. & Green, A.R. (2005) on the behalf of the Cancer Genome Project. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet, 365, 1054-1061.
2. Jaffe, E.S., Harris, N.L., Stein, H. & Vardiman, J.W. (Eds.) (2001) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon.
3. Kralovics, R., Passamonti, F., Buser, A.S., Teo, S.S., Tiedt, R., Passweg, J.R., Tichelli, A., Cazzola, M. & Skoda, R.C. (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. New England Journal of Medicine, 352, 1779-1790.
4. Kralovics, R., Teo, S.S., Li, S., Theocharides, A., Buser, A.S., Tichelli, A. & Skoda, R.C. (2006) Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders. Blood, 108, 1377-1380.
5. Mesa, R.A., Powell, H., Lasho, T., Dewald, G., McClure, R. & Tefferi, A. (2006) JAK2(V617F) and leukemic transformation in myelofibrosis with myeloid metaplasia. Leukemia Research, DOI:10.1016/j.leukres.2006.01.008.
6. V617F mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance. British Journal of Haematology, 131, 208-213.